Author
Listed:
- Mirko Trajkovski
(Institute for Molecular Systems Biology, ETH Zurich, Wolfgang-Pauli Strasse 16, CH-8093 Zurich, Switzerland
Competence Center of Systems Physiology and Metabolic Disease, ETH Zurich, Schafmattstrasse 18, HPM F 39.1 CH-8093 Zurich, Switzerland)
- Jean Hausser
(Competence Center of Systems Physiology and Metabolic Disease, ETH Zurich, Schafmattstrasse 18, HPM F 39.1 CH-8093 Zurich, Switzerland
Biozentrum Basel, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland)
- Jürgen Soutschek
(Regulus Therapeutics Inc., 3545 John Hopkins Court)
- Bal Bhat
(Regulus Therapeutics Inc., 3545 John Hopkins Court)
- Akinc Akin
(Alnylam Pharmaceuticals, 300 Third Street)
- Mihaela Zavolan
(Biozentrum Basel, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland)
- Markus H. Heim
(Competence Center of Systems Physiology and Metabolic Disease, ETH Zurich, Schafmattstrasse 18, HPM F 39.1 CH-8093 Zurich, Switzerland
University Hospital Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland)
- Markus Stoffel
(Institute for Molecular Systems Biology, ETH Zurich, Wolfgang-Pauli Strasse 16, CH-8093 Zurich, Switzerland
Competence Center of Systems Physiology and Metabolic Disease, ETH Zurich, Schafmattstrasse 18, HPM F 39.1 CH-8093 Zurich, Switzerland)
Abstract
A new target for diabetes and obesity drugs A microRNA (miRNA) microarray analysis of the livers of two mouse models of obesity show that the expression of miRNA-103 and miRNA-107 is upregulated in obesity. Silencing these miRNAs improves glucose homeostasis and insulin sensitivity. Turning them on in liver or fat is sufficient to impair glucose homeostasis. Caveolin-1, a protein involved in regulation of insulin signalling, is a direct target gene of the miRNAs. These findings show that these miRNAs regulate insulin sensitivity and identify a new potential target for the treatment of type 2 diabetes and obesity.
Suggested Citation
Mirko Trajkovski & Jean Hausser & Jürgen Soutschek & Bal Bhat & Akinc Akin & Mihaela Zavolan & Markus H. Heim & Markus Stoffel, 2011.
"MicroRNAs 103 and 107 regulate insulin sensitivity,"
Nature, Nature, vol. 474(7353), pages 649-653, June.
Handle:
RePEc:nat:nature:v:474:y:2011:i:7353:d:10.1038_nature10112
DOI: 10.1038/nature10112
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:474:y:2011:i:7353:d:10.1038_nature10112. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.